Immuneel Therapeutics Pvt. Ltd., a leading clinical-stage startup revolutionizing Cell & Gene therapy in India, has successfully raised an impressive $12,000,000 in funding. Specializing in pioneering cancer treatments, Immuneel Therapeutics is dedicated to making cutting-edge therapies accessible and affordable to patients across the country. This substantial funding will significantly boost the company's research and development efforts, enabling them to further advance their innovative treatments and bring new hope to those battling cancer. Immuneel Therapeutics' success in securing this funding highlights the growing interest and support for revolutionary healthcare solutions that have the potential to make a lasting impact on patients' lives.










.png&w=3840&q=75)


